Reported Cases
1
2
Abbott Laboratories Ltd. v. Canada (Attorney General),
[2009] 3 F.C.R. 547;
2008 FCA 354
(November 17, 2008)
3
Abbott Laboratories v. Canada (Minister of Health) (F.C.A.),
[2008] 1 F.C.R. 725;
2007 FCA 187
(May 16, 2007)
4
5
6
7
8
9
10
11
AstraZeneca Canada Inc. v. Canada (Minister of Health) (F.C.),
[2005] 2 F.C.R. 123;
2004 FC 1278
(September 20, 2004)
12
AstraZeneca Canada Inc. v. Canada (Minister of Health) (F.C.A.),
[2006] 2 F.C.R. 371;
2005 FCA 208
(June 2, 2005)
13
Baker Petrolite Corp. v. Canwell Enviro-Industries Ltd. (C.A.),
[2003] 1 F.C. 49;
2002 FCA 158
(April 29, 2002)
14
15
16
17
18
19
20
21
Hoechst Marion Roussel Canada Inc. v. Canada (Attorney General) (F.C.),
[2006] 3 F.C.R. 536;
2005 FC 1552
(November 17, 2005)
22
ICN Pharmaceuticals, Inc. v. Canada (Staff of the Patented Medicine Prices Review Board) (C.A.),
[1997] 1 F.C. 32;
(August 7, 1996)
23
24
Merck Frosst Canada Inc. v. Canada (Minister of National Health and Welfare) (T.D.),
[1997] 3 F.C. 752;
(June 13, 1997)
25
Novopharm Ltd. v. Canada (Minister of National Health and Welfare) (T.D.),
[1998] 3 F.C. 50;
(February 3, 1998)
26
Parke-Davis Division v. Canada (Minister of Health) (C.A.),
[2003] 2 F.C. 514;
2002 FCA 454
(November 18, 2002)
27
Parke-Davis Division v. Canada (Minister of Health) (T.D.),
[2002] 1 F.C. 517;
2001 FCT 931
(August 22, 2001)
28
Pason Systems Corp. v. Canada (Commissioner of Patents) (F.C.),
[2007] 2 F.C.R. 269;
2006 FC 753
(June 13, 2006)
29
30
Pfizer Canada Inc. v. Canada (Attorney General) (C.A.),
[2003] 4 F.C. 95;
2003 FCA 138
(March 14, 2003)
31
Pfizer Canada Inc. v. Canada (Attorney General) (T.D.),
[2003] 1 F.C. 423;
2002 FCT 706
(June 25, 2002)
32
Pfizer Canada Inc. v. Canada (Minister of Health) (F.C.A.),
[2007] 2 F.C.R. 137;
2006 FCA 214
(June 9, 2006)
Digests
33
34
Abbott Laboratories Ltd. v. Canada (Attorney General),
[2008] 4 F.C.R. D-15;
2008 FCA 186
(May 20, 2008)
35
Abbott Laboratories v. Canada ( Minister of Health ),
[2005] 1 F.C.R. D-26;
2004 FCA 154
(April 19, 2004)
36
Abbott Laboratories v. Canada (Minister of Health),
[2006] 4 F.C.R. D-32;
2006 FCA 187
(May 18, 2006)
37
Abbott Laboratories v. Canada (Minister of Health),
[2007] 3 F.C.R. D-15;
2007 FCA 153
(April 19, 2007)
38
Abbott Laboratories v. Canada (Minister of Health),
[2009] 4 F.C.R. D-17;
2009 FCA 94
(March 20, 2009)
39
40
Antiballistic Security and Protection Inc. v. Canada (Commissioner of Patents),
[2008] 4 F.C.R. D-15;
2008 FC 587
(May 8, 2008)
41
42
Apotex Inc. v. Canada ( Minister of National Health and Welfare ),
[1997] 3 F.C. 0;
(September 29, 1997)
43
Apotex Inc. v. Canada ( Minister of National Health and Welfare ),
[1999] 1 F.C. D-14;
(July 29, 1998)
44
45
46
Apotex Inc. v. Syntex Pharmaceuticals International Ltd.,
[2009] 4 F.C.R. D-5;
2009 FC 494
(May 12, 2009)
47
48
49
AstraZeneca Canada Inc. v. Canada ( Minister of Health ),
[2005] 3 F.C.R. D-6;
2004 FC 736
(May 20, 2004)
50
51
52
53
Aventis Pharma Inc. v. Mayne Pharma (Canada) Inc.,
[2008] 2 F.C.R. D-8;
2008 FCA 21
(January 15, 2008)
54
55
56
57
Bayer Inc. v. Canada ( Minister of National Health and Welfare ),
[1999] 1 F.C. D-14;
(July 20, 1998)
58
Bayer Inc. v. Canada ( Minister of National Health and Welfare ),
[2000] 3 F.C. D-41;
(April 7, 2000)
59
Bristol-Myers Squibb Co. v. Canada ( Attorney General ),
[2003] 3 F.C. D-10;
2002 FCT 1205
(November 22, 2002)
60
Canada (Minister of Health) v. Pfizer Canada Inc.,
[2006] 3 F.C.R. D-22;
2004 FCA 402
(December 1, 2004)
61
Canadian Generic Pharmaceutical Assn. v. Canada (Minister of Health),
[2009] 4 F.C.R. D-5;
2009 FC 725
(July 17, 2009)
62
Carbo Ceramics Inc. v. China Ceramic Proppant Ltd.,
[2005] 4 F.C.R. D-9;
2004 FCA 283
(September 2, 2004)
63
64
65
66
67
Eli Lilly Canada Inc. v. Canada ( Minister of Health ),
[2002] 3 F.C. D-9;
2002 FCT 28
(January 10, 2002)
68
Glaxo Wellcome Inc. v. Canada ( Minister of National Health and Welfare ),
[1998] 1 F.C. D-21;
(August 19, 1997)
69
GlaxoSmithKline Inc. v. Canada ( Attorney General ),
[2005] 4 F.C.R. D-41;
2004 FC 1302
(September 23, 2004)
70
GlaxoSmithKline Inc. v. Canada (Attorney General),
[2006] 3 F.C.R. D-20;
2005 FCA 197
(May 24, 2005)
71
72
H. Lundbeck A/S v. Canada ( Ministre de la Santé ),
[2004] 2 F.C.R. D-26;
2003 FC 1333
(November 12, 2003)
73
Hoffman-La Roche Ltd. v. Canada ( Minister of National Health and Welfare ),
[1996] 3 F.C. 0;
(March 20, 1996)
74
Hoffmann-La Roche Ltd. v. Canada ( Minister of National Health and Welfare ),
[1996] 1 F.C. 0;
(June 21, 1995)
75
Hoffmann-La Roche Ltd. v. Canada ( Minister of National Health and Welfare ),
[1999] 2 F.C. D-47;
(January 13, 1999)
76
Hoffmann-La Roche Ltd. v. Canada ( Minister of National Health and Welfare ),
[1999] 2 F.C. D-47;
(January 13, 1999)
77
Hoffmann-La Roche Ltd. v. Canada ( Minister of National Health and Welfare ),
[1999] 2 F.C. F-47;
(January 26, 1999)
78
79
80
ICN Pharmaceuticals, Inc. v. Canada ( Patented Medicines Prices Review Board ),
[1996] 2 F.C. 0;
(February 15, 1996)
81
82
83
84
85
86
Merck Frosst Canada & Co. v. Canada ( Minister of Health ),
[2001] 4 F.C. D-10;
2001 FCA 136
(May 1, 2001)
87
88
Merck Frosst Canada Inc. v. Canada ( Minister of Health and Welfare ),
[1997] 1 F.C. 0;
(February 7, 1997)
89
Merck Frosst Canada Inc. v. Canada ( Minister of National Health and Welfare ),
[1997] 1 F.C. 0;
(December 13, 1996)
90
Merck Frosst Canada Inc. v. Canada ( Minister of National Health and Welfare ),
[1999] 2 F.C. D-24;
(December 18, 1998)
91
Merck Frosst Canada Inc. v. Canada ( Minister of National Health and Welfare ),
[2000] 4 F.C. D-42;
(June 27, 2000)
92
93
Novartis Pharmaceuticals Canada Inc. v. Canada ( Minister of Health ),
[2003] 2 F.C. D-27;
2002 FCT 1042
(October 7, 2002)
94
95
96
97
98
99
Pfizer Canada Inc. v. Canada ( Attorney General ),
[2005] 1 F.C.R. D-25;
2004 FC 370
(March 11, 2004)
100
